
Memorial Hermann Health System is a nonprofit, community-owned integrated health system based in Houston, Texas, that makes corporate venture capital investments in healthcare and digital health companies through its Strategic Innovation arm. It has invested in over 40 companies, targeting strategic partnerships that accelerate value-based care and solve long-term healthcare challenges.
76% of their portfolio is in Healthcare. Deal activity decreased year-over-year (3 deals in the last 12 months vs 5 prior). Average disclosed round size is $72.1M (across 20 rounds with reported amounts).
Portfolio
23
Fund Size
—
Top Stage
Series C
Last 12 Mo
3
Team
Emily Weber, DNP, RN, CPN, NEA-BC
Vice President and Chief Nursing Officer/Operations, Children’s Memorial Hermann Hospital
Guy B. Giesecke, DHA, FACHE
Senior Vice President and Chief Executive Officer , Children’s Memorial Hermann Hospital
Kevin P. Lally, MD
Surgeon-in-Chief, Children’s Memorial Hermann Hospital; Professor and Chairman, Department of Pediatric Surgery
Mary E. Aitken, MD, MPH, FAAP
Pediatrician-in-Chief, Children’s Memorial Hermann Hospital and Chair, Department of Pediatrics, McGovern Medical School at UTHealth
Sean C. Blackwell, MD
Chief of Service, Obstetrics and Gynecology, Children’s Memorial Hermann Hospital; Professor and Chair, Department of Obstetrics, Gynecology and Reproductive Sciences
Todd Centurino
Vice President, Managing Director & Head of Private Markets
Kris Chikelue
Chief Investment Officer
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Series D | $97M | Sep 2025 | |
| Series B | $20M | Sep 2025 | |
| Series A | $26M | Sep 2025 | |
| Series C | $8M | May 2025 | |
| Series B | $18.3M | May 2025 | |
| Unknown | $15M | Jan 2025 | |
| Series F | $252M | Jan 2025 | |
| Series C | $51.5M | Oct 2024 | |
| IInfinitus Systems | Series C | $51.5M | Oct 2024 |
| Seed | $14M | Aug 2024 | |
| Series A | — | May 2024 | |
| Series D | $126M | May 2024 | |
| Series B | — | Apr 2024 | |
| Series C | $53M | Mar 2024 | |
| Series D | $126M | Jan 2024 | |
| Growth | $50M | Oct 2023 | |
| Unknown | — | Jun 2023 | |
| Series B | $25M | Jun 2023 | |
| WWellvana Health | Growth | — | Mar 2023 |
| Series A | $10M | Jan 2023 | |
| EEnableComp | Unknown | — | Jul 2022 |
| Unknown | $84M | Jan 2020 | |
| Series C | $20M | Oct 2018 | |
| Series C | $20M | Oct 2018 | |
| Unknown | $375M | — |
Top Co-Investors
Last updated: 9 September 2026